Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of BEMA Buprenorphine in Chronic Pain
NCT01298765Phase 3Completed
- Sponsor
- BioDelivery Sciences International
- Start
- Mar 2011
- Primary completion
- Aug 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of buprenorphine in chronic pain, low back pain (LBP), osteoarthritis (OA) and 1 more, sponsored by BioDelivery Sciences International. Primary endpoint: Numeric Rating Scale Pain Intensity at 52 weeks. Started Mar 2011; status: completed.
02
Drugs
buprenorphine
03
Conditions
chronic painlow back pain (LBP)osteoarthritis (OA)neuropathic pain
Beyond the preview
Go deeper on NCT01298765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298765.